Christopher Mutz News Today

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 2,000 shares of the stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $61.61, for a total value of $123,220.00. Following the completion of the transaction, the insider now directly owns 83,277 shares […]

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 2,000 shares of the stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $61.61, for a total value of $123,220.00. Following the transaction, the insider now directly owns 83,277 shares in the company, valued at […]

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $61.61, for a total value of $123,220.00. Following the transaction, the insider now owns 83,277 shares of the company’s […]

/PRNewswire/ -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) and Veeva Systems (NYSE: VEEV) today announced a collaboration to define and operationalize...

ANI Pharmaceuticals, Inc. today announced the U.S. commercial availability of Purified Cortrophin™ Gel 80 U/mL. The commercial launch of Cortrophin Gel, an adrenocorticotropic hormone , also... | January 24, 2022